Wei-Jing Li Selected Research

Leukemia

6/2016	[Clinical Characteristics and Treatment Efficacy of Children with SIL/TAL1 Positive T-Cell Acute Lymphoblastic Leukemia].
12/2011	[Gene rearrangement pattern of immunoglobulin and T-cell receptor (Ig/TR) and its clinical characteristics in children with SET-NUP214 fusion gene-positive leukemia/lymphoma].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wei-Jing Li Research Topics

Disease

8	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 06/2011
7	Residual Neoplasm 08/2017 - 11/2012
3	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2023 - 01/2021
3	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 06/2016 - 11/2012
2	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 01/2021 - 09/2020
2	Leukemia 06/2016 - 12/2011
2	Infections 04/2014 - 12/2011
1	Panniculitis 01/2023
1	Epstein-Barr Virus Infections 01/2022
1	Body Weight (Weight, Body) 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Pathologic Complete Response 02/2015
1	Exanthema (Rash) 08/2012
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2012
1	Lymphoma (Lymphomas) 12/2011
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 12/2011

Drug/Important Bio-Agent (IBA)

6	Prednisone (Sone)FDA LinkGeneric 08/2017 - 11/2012
3	ruxolitinibIBA 01/2023 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2013
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 08/2012
2	Methotrexate (Mexate)FDA LinkGeneric 06/2017 - 04/2014
2	Caspase 8 (Caspase-8)IBA 02/2015 - 10/2013
1	CaspasesIBA 01/2023
1	Cell-Free Nucleic AcidsIBA 01/2021
1	CytokinesIBA 01/2021
1	Long Noncoding RNAIBA 01/2019
1	folylpolyglutamate synthetaseIBA 04/2014
1	thiopurine methyltransferase (thiopurine S-methyltransferase)IBA 08/2012
1	RNA (Ribonucleic Acid)IBA 08/2012
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 08/2012
1	Small Interfering RNA (siRNA)IBA 04/2012
1	Nicotinamide PhosphoribosyltransferaseIBA 04/2012
1	Imatinib Mesylate (Gleevec)FDA Link 04/2012
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2011
1	Immunoglobulins (Immunoglobulin)IBA 12/2011
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 06/2011

Therapy/Procedure

6	Therapeutics 01/2021 - 06/2011
3	Drug Therapy (Chemotherapy) 09/2020 - 12/2011
2	Remission Induction 06/2016 - 04/2014
1	Immunotherapy 01/2019